Institut De Cancerologie De L Ouest — Clinical Trial Site

443 Registered trials

252 Currently recruiting

Organisation

Institut De Cancerologie De L Ouest

Location

Saint-Herblain Cedex, France

Identifier

ORG-100010298

Address

Boulevard Jacques Monod, 44805, France

Departments

#1000: Medical Oncology
#1205: Medecine Nucleaire
#2160: Radiology
#3507; Medical Oncology
033001:Oncology
03310: Oncology
1001:Medecine nucleaire
1205: Oncologie Médicale
1207: Medecine Nucleaire
1306: Departement d'oncologie Medicale/Unite de Developpement des Therapeutiques Precoces
2105:Oncology
2301 Oncology Medical
2303:Service Oncologie Medicale
2304: Medical Oncology
2309 Oncology Medical
250004:Oncology
250009: Département d'Oncologie
301: Medical Oncology
3097:Oncology
3201:Medical Oncology
33005: Oncologie Médicale
4001: Oncologie
4004: Medical Oncology 
402 : Medical Oncology
4407:Medical Oncology
Anesthésie Douleur
Cardiology
Centre d'investigation Clinique Thorax (équipe Cardiovasculaire
Chirurgie Digestive
Chirurgie gynécologique
Chirurgie Oncologique Gynécologique
Département d'anesthésiologie, et médecine de la douleur
Departement d'Oncologie
Departement d'oncologie - radiotherapie
Département d'Oncologie Médicale
Département d’oncologie médicale
Département d’oncologie médicale- sénologie et neuro-oncologie Unité des thérapeutiques précoces
Département de radiothérapie
Dermatology
digestif
Digestive Oncology
Digestive surgery
Early Therapeutics Development Unit
FRA003: Servce d'Oncologie Médicale
FRA03-0: Medical Oncology
Gynaecologic Oncology
Gynecologie
Gynecologie medicale
Hepatogastroenterology
Institut de Cancérologie de l’Ouest
Institut de Cancérologie de l’Ouest Saint Herblain
Maine-et-Loire
Medecine nucleaire
medecine nuclear department
Medical
Medical Oncologist
medical oncology
Medical Oncology Department
Medical Oncology Departmet
N/A
NA
Nuclear Medicine
Oncogénétique
Oncolgie
Oncologie
Oncologie Médicale
Oncologie Chirurgie et Anesthesie
Oncologie digestive
Oncologie Médical
Oncologie médicale
Oncologie médicale - essais précoces
ONCOLOGIE OPTION MEDICALE
Oncologie Radiothérapie
Oncologue
Oncology
Oncology clinic
Oncology department
Oncology medical
Pays de Loire, Department of oncology
pneumology
Pulmonary Oncology
Radiothérapie
Radiotherapist
Radiotherapy
Radiotherapy Departement
Radiotherapy department
Radiotherapy for pediatrics and adults
Service d' Oncologie Médicale
Service d'Oncologie
Service d'Oncologie Médicale
Service d’Oncologie Médicale
Service de Cancérologie
Service de Chirurgie Digestive
Service oncologie
Service Oncologie médicale
Service Oncologie-Radiothérapie
Site de SAINT-HERBLAIN - Département d'Oncologie Médicale
Site René Gauducheau
Supportive care
Surgery
Surgical Oncology

Clinical trials at this site (443)

Search interface

Clinical trial of MK-7648A in adults and children with skin cancer Not authorised

2022-501417-31-00 High-risk Resected Melanoma 5
HARMONi-3 Not authorised

2023-504989-37-00 Metastatic Squamous Non-small Cell Lung Cancer 5
Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno… Not authorised

2023-506014-47-00 Resected (R0 or R1) pancreatic ductal adenocarcinoma 9
ExplOratory, Phase 0 Study to assess biodisTribution and PosItron EMission Tomography (PET) Imaging kinetics of [64Cu]Cu-PSMA-R2 in metaStat… Not authorised

2023-508473-86-00 metastatic prostate cancer 3
Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Not authorised

2024-512754-16-00 Prostate cancer 5
A First In Human Phase I Trial Evaluating safety, tolErability and ResponSe of [211At]At-Girentuximab (ATO-101™) in PatiEnts with Non-Muscle… Pending

2023-509729-33-00 Non-Muscle-Invasive Bladder Cancer (NMIBC) refractory 1
Study of the effect and tolerability of INT230-6 by direct injection into the tumor, followed by neoadjuvant treatment with chemoimmunothera… Pending

2024-512511-49-00 Early triple-negative breast cancer (TNBC) 4
Prospective feasibility pilot study evaluating the value of [68Ga]Ga-PENTIXAFOR PET-CT in patients with locally advanced or metastatic Small… Pending

2024-514057-30-00 cell lung carcinoma 3
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patients Pending

2024-514144-85-02 Glioblastoma 3
TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma: A single-arm Phas… Pending

2024-516182-37-01 Maintenance treatment in patients with locally advanced 4
ALADDIN: evaluation of dAroLutamide Addition to anDrogen Deprivation therapy and radIatioN therapy in newly diagnosed prostate cancer with p… Pending

2024-517285-41-00 Newly diagnosed prostate cancer with pelvic lymph nodes 5
A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Anti_Tumor Activity of AVZO-02… Pending

2024-517339-30-00 Advanced Solid Tumors 7
Multicenter, randomized, double-blinded, placebo-controlled phase 3 trial to evaluate nonavalent HPV vaccine as a secondary prevention in pa… Pending

2024-520140-42-00 Patients with primary HPV high-grade squamous intra-epi 5
Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad… Pending

2025-521221-32-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5
Phase II study of ficerafusp alfa in combination with nivolumab in patients with platinum-refractory head and neck squamous cell carcinoma w… Pending

2025-521437-88-00 head and neck squamous cell carcinoma 4
Study evaluating two treatment strategies for rectal cancer in patients ≥75 years old Pending

2025-521619-37-00 Patients ≥75 years old with cT3/T4 rectal adenocarcinom 5
IZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after… Pending

2025-521908-22-00 EGFR-mutated Non-small Cell Lung Cancer 10
Clinical trial evaluating the biological activity of a new drug identified as prifetrastat (PF-07248144), combined with fulvestrant for the … Pending

2025-521982-29-00 Adult patients with advanced hormone receptor positive 4
Phase 1/2 study to investigate the safety and preliminary efficacy of GSK5460025 alone or in combination with other anti-cancer agents in dM… Pending

2025-522318-21-00 Neoplasms, Colorectal 7
A Phase 1/2 Study of Inhaled KB707 in Patients Pending

2025-522723-98-00 solid tumor 9
Personnalized immunotherapy in patients with stage III non-small cell lung cancer Pending

2025-522801-39-00 Stage III Non Small Cell Lung Cancer 4
A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell L… Pending

2025-522818-23-00 Small Cell Lung Cancer (SCLC) 5
A Phase 1/2, Open-label Study of VS-7375, a KRAS G12D (ON/OFF) Inhibitor, as Monotherapy and in Combination, in Patients with Advanced KRAS … Pending

2025-523432-39-01 Advanced KRAS G12D-Mutant Solid Tumors 9
Rollover study for participants who are currently being treated with and are continuing to benefit from opnurasib as a single agent or in co… Pending

2025-523537-26-00 Locally advanced or metastatic KRAS G12C-mutated non-sm 9